T cells

Selective serotonin reuptake inhibitors (SSRIs) enhanced the ability of T cells to fight cancer and suppressed tumour growth across a range of cancer types in both mouse and human tumour models. The study, published in Cell, May 20, further showed…

A combination of existing drugs may inhibit development of bone metastasis in breast cancer patients. The study published in Cancer Discovery, 1 March, found that a combined treatment strategy that activates T cells while at the same time targeting cells…

The Cancer Grand Challenges initiative has announced the five global research teams who between them will receive $125 million to address unanswered questions. The winning teams, revealed in March, are addressing four major oncology challenges – solid tumours in children,…